GleamWall
中文EN

FMS Fresenius Medical Care AG IFRS

Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 1333141 · Reporting currency EUR

Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.5%
TTM net income YoY81.9%
TTM EPS YoY83.6%
Revenue 3-yr CAGR0.4%
Net income 3-yr CAGR13.3%

Margins

Gross margin25.6%
Operating margin9.3%
Net margin5.0%
FCF margin—
EBITDA margin16.8%

Returns

ROE7.0%
ROA3.0%
ROIC (approx.)7.3%
Asset turnover0.61x

Leverage & solvency

Liabilities / assets53.9%
Debt / equity0.55x
Current ratio1.26x
Interest coverage4.87x

Cash quality & payout

Operating cash flow / net income2.74x
Accruals ratio-5.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Unit: EUR FY20252025-12-31FY20242024-12-31
Income statement
Revenue19.63B19.34B
Cost of revenue14.60B14.58B
Gross profit5.03B4.76B
R&D expense157.97M183.49M
SG&A expense3.03B3.14B
Operating income1.83B1.39B
Interest expense375.22M393.32M
Pretax income1.51B1.06B
Income tax320.97M316.06M
Net income978.37M537.91M
EBITDA3.29B2.93B
EPS (basic)3.361.83
EPS (diluted)3.361.83
Banking
Net interest income-314.80M-335.47M
Balance sheet
Cash & equivalents1.60B1.18B
Inventory2.14B2.07B
Current assets7.90B7.92B
PP&E, netmay include right-of-use assets (IFRS)3.49B3.65B
Goodwill13.57B15.17B
Intangibles1.25B1.37B
Total assets31.00B33.57B
Current liabilities6.25B5.66B
Short-term debt1.60B575.28M
Long-term debt5.69B6.26B
Total debt7.29B6.84B
Total liabilities16.72B17.80B
Shareholders' equity13.31B14.58B
Net debt5.69B5.66B
Shares outstanding279.29M293.41M
Cash flow statement
Operating cash flow2.68B2.39B
Investing cash flow-722.53M-84.94M
Financing cash flow-1.40B-2.57B
Depreciation & amortization1.46B1.54B
Dividends paid422.51M349.16M
Share buybacks585.28M—

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· Amounts are in the company's reporting currency, EUR, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.